SHIKARI® Q-PEM
Matriks Biotek® pembrolizumab ELISA has been specially developed for the quantitative analysis of Pembrolizumab in serum and plasma samples between the Cmin and Cmax range of concentrations (indicated in the pharmacokinetics section of protocol linked below).
SHIKARI® S-ATP
Required Volume 
Total Time 
Sample
Sample Number
Detection Limit 
Spike Recovery 
Shelf Life
10ul
140 min
Serum, plasma
96
30ng/mL
85-115%
1 year
The Matriks Biotek anti-Pembrolizumab (Keytruda®) Enzyme-Linked ImmunoSorbentAssay (ELISA) Kit is intended for the qualitative determination of antibodies to Pembrolizumab (Keytruda®) in serum and plasma. It is for professional use only.
Calibration Curve
SHIKARI® Q-PEM & S-ATP
Pembrolizumab (Keytruda®)
Enzyme immunoassay for the quantitative determination of Pembrolizumab (Keytruda®) in serum and plasma
Enzyme immunoassay for the qualitative determination (screening) of antibodies to Pembrolizumab (Keytruda®) in serum and plasma
Required Volume 
Total Time 
Sample
Sample Number
Detection Limit 
Spike Recovery 
Shelf Life
10ul
140 min
Serum, plasma
96
+/-
-
1 year
Q-PEMv1: $943.00                                            Lead time: 1-2 weeks
S-ATPv1: $878.00                                             Lead time: 1-2 weeks
.....................................................
.....................................................
Drug Measurement
Anti-drug Antibody Measurement
Quantitative
Qualitative
Pembrolizumab (Keytruda®)
PD-1, PD-L1 and CTLA-4
Q-PEM
(Free)

#TR-PEMv1
S-ATP
(Free)

#TR-A-PEMv1
Iwai North America Inc.

541 Taylor Way Suite# 4
 San Carlos, CA 94070
 Phone : (650) 486-1541
Fax : (650) 394-8638
 Open weekdays 9 AM-6 PM (PST)
.........................................................................................................................................................................................................................................................